OK, I'm trading it short. Long term it will be a good one, but this is way overdone for a Phase II
I am the one on the other side of your trade.
Just FYI, Accelerated Approval allows a company to sell the drug after phase II while confirmatory studies are done. A bit more than "just a phase II"
Sentiment: Strong Buy
You should short this stock. When AA is announced, my guess is should run 80-120$ with short fuel and settle 60-80 for a while as shorts cover. Then slower climb over the next year.